Researchers introduced a benchmarking study assessing how large language models can be used in RNA biomarker discovery for cell-free RNA (cfRNA) diagnostics, aiming to improve reproducibility and performance clarity in a field where AI methods often lack systematic evaluation. Published in Nature Communications, the work by Gaudio, Bliss, Loy and colleagues positions LLMs as a potential accelerant for cfRNA candidate prioritization. In parallel, TOFU-MAaPO was presented as a fast, scalable computational tool for analyzing large metagenomic datasets, designed for reproducible pipelines. The combination of LLM benchmarking and scalable metagenomics analysis reflects a push toward better computational throughput and evaluation frameworks for biological discovery. These updates land as the genomics toolchain becomes increasingly central to drug development, from biomarker selection to microbiome-informed hypotheses, and both publications focus on the operational limits that have constrained prior AI- and compute-heavy approaches.